245 related articles for article (PubMed ID: 35144669)
41. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
42. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
bioRxiv; 2023 Nov; ():. PubMed ID: 37961092
[TBL] [Abstract][Full Text] [Related]
43. Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
Smith EM; Rubenstein LM; Ritchie JM; Lee JH; Haugen TH; Hamsikova E; Turek LP
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2087-96. PubMed ID: 18708401
[TBL] [Abstract][Full Text] [Related]
44. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
46. Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers.
Reid P; Staudacher AH; Marcu LG; Olver I; Moghaddasi L; Brown MP; Bezak E
Sci Rep; 2020 Feb; 10(1):2716. PubMed ID: 32066820
[TBL] [Abstract][Full Text] [Related]
47. Human papillomavirus (HPV) DNA methylation changes in HPV-associated head and neck cancer.
Ekanayake Weeramange C; Tang KD; Irwin D; Hartel G; Langton-Lockton J; Ladwa R; Kenny L; Taheri T; Whitfield B; Vasani S; Punyadeera C
Carcinogenesis; 2024 Mar; 45(3):140-148. PubMed ID: 38270218
[TBL] [Abstract][Full Text] [Related]
48. Human Papilloma Virus Increases ΔNp63α Expression in Head and Neck Squamous Cell Carcinoma.
Citro S; Bellini A; Medda A; Sabatini ME; Tagliabue M; Chu F; Chiocca S
Front Cell Infect Microbiol; 2020; 10():143. PubMed ID: 32322564
[TBL] [Abstract][Full Text] [Related]
49. Role of human papillomavirus in non-oropharyngeal head and neck cancers.
Combes JD; Franceschi S
Oral Oncol; 2014 May; 50(5):370-9. PubMed ID: 24331868
[TBL] [Abstract][Full Text] [Related]
50. Biomarkers of HPV in head and neck squamous cell carcinoma.
Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
[TBL] [Abstract][Full Text] [Related]
51. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
[TBL] [Abstract][Full Text] [Related]
52. Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment.
Campisi G; Giovannelli L
Head Neck Oncol; 2009 Mar; 1():8. PubMed ID: 19331691
[TBL] [Abstract][Full Text] [Related]
53. DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Tang KD; Vasani S; Langton-Lockton J; Kenny L; Punyadeera C
Cells; 2020 May; 9(6):. PubMed ID: 32486347
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.
Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS
mBio; 2014 Dec; 5(6):. PubMed ID: 25538195
[TBL] [Abstract][Full Text] [Related]
55. 4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells.
Shishodia G; Toledo RRG; Rong X; Zimmerman E; Xiao AY; Harrison L; Nathan CO
Oral Oncol; 2021 Nov; 122():105578. PubMed ID: 34695758
[TBL] [Abstract][Full Text] [Related]
56. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
[TBL] [Abstract][Full Text] [Related]
57. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
58. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus.
Wald AI; Hoskins EE; Wells SI; Ferris RL; Khan SA
Head Neck; 2011 Apr; 33(4):504-12. PubMed ID: 20652977
[TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.
Lace MJ; Anson JR; Klussmann JP; Wang DH; Smith EM; Haugen TH; Turek LP
J Virol; 2011 Feb; 85(4):1645-54. PubMed ID: 21123375
[TBL] [Abstract][Full Text] [Related]
60. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
